The ThyroSeq® test utilizes cutting-edge science to offer the most personalized management for patients with thyroid nodules and cancer.

We offer an optimal level of testing and diagnostic services to address diseases that affect female patients.

AuraSeq uses next-generation sequencing (NGS) technology enabling the testing of multiple biomarkers, such as somatic variants in oncogenic driver genes, in a single assay. 

We utilize the most accurate and up-to-date testing platforms and methodologies, under the guidance of our COVID-19 Task Force, to best detect and prevent the spread of COVID-19 in our communities.